Shattuck Labs (STTK) Total Liabilities (2019 - 2026)
Shattuck Labs (STTK) reported Total Liabilities of $6.3 million for Q1 2026, down 34.39% year-over-year from $9.6 million in Q1 2025, and down 27.21% quarter-over-quarter from $8.6 million in Q4 2025.
Shattuck Labs (STTK) Total Liabilities (2019 - 2026) Analysis & Trends
Shattuck Labs (STTK) has 8 years of Total Liabilities data on file, last reported at $6.3 million in Q1 2026.
- Total Liabilities for Q1 2026 came in at $6.3 million, down 34.39% year-over-year; the trailing twelve-month figure through Mar 2026 was $6.3 million (down 34.39% YoY), and the FY2025 annual result was $8.6 million, down 24.4% from the prior year.
- Total Liabilities retreated to $6.3 million in Q1 2026 per STTK's latest filing, from $8.6 million in the prior quarter.
- Over five years, Total Liabilities peaked at $29.2 million in Q4 2022 and troughed at $6.3 million in Q1 2026.
- A 5-year average of $16.1 million and a median of $16.8 million in 2023 frame the typical range for Total Liabilities.
- The sharpest annual moves came in 2022 and 2025: Total Liabilities gained 8.84% in 2022, then tumbled 59.15% in 2025.
- A 5-year view of Total Liabilities shows it stood at $29.2 million in 2022, then sank by 49.06% to $14.9 million in 2023, then dropped by 23.12% to $11.4 million in 2024, then fell by 24.4% to $8.6 million in 2025, then dropped by 27.21% to $6.3 million in 2026.
- Business Quant data shows STTK's Total Liabilities at $6.3 million in Q1 2026, $8.6 million in Q4 2025, and $7.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 1.74 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 15.48 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 16.35 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 731.60 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 10.44 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 19.51 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 943,068.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 7.12 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 137.56 Mn |
| 10 | Shattuck Labs | 190.32 Mn | 190.32 Mn | - | 6.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.29 Mn |
| Dec 31, 2025 | 8.64 Mn |
| Sep 30, 2025 | 7.09 Mn |
| Jun 30, 2025 | 7.35 Mn |
| Mar 31, 2025 | 9.58 Mn |
| Dec 31, 2024 | 11.42 Mn |
| Sep 30, 2024 | 15.14 Mn |
| Jun 30, 2024 | 18.00 Mn |
| Mar 31, 2024 | 17.52 Mn |
| Dec 31, 2023 | 14.86 Mn |
| Sep 30, 2023 | 17.67 Mn |
| Jun 30, 2023 | 16.81 Mn |
| Mar 31, 2023 | 20.02 Mn |
| Dec 31, 2022 | 29.17 Mn |
| Sep 30, 2022 | 23.53 Mn |
| Jun 30, 2022 | 28.81 Mn |
| Mar 31, 2022 | 21.55 Mn |
| Dec 31, 2021 | 26.80 Mn |
| Sep 30, 2021 | 49.40 Mn |
| Jun 30, 2021 | 46.69 Mn |